Emily Lemke
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
-
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 8
- Surgery 7
- Bladder and Urothelial Cancer Treatments 6
- Urinary and Genital Oncology Studies 5
- Co-authors
- Amishi Y. Shah (8 shared papers)Nizar M. Tannir (6 shared papers)Matthew T. Campbell (8 shared papers)Eric Jonasch (5 shared papers)Pavlos Msaouel (3 shared papers)Jianjun Gao (4 shared papers)Anuradha Chandramohan (4 shared papers)Martin H. Voss (2 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)European Journal of Cancer (2 papers)Clinical Genitourinary Cancer (2 papers)Annals of Oncology (1 paper)Oncology nursing forum (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
Emily Lemke
19 papers receiving 216 citations
Peers
Comparison fields: 5 of 42
- Pulmonary and Respiratory Medicine 154
- Cancer Research 45
- Oncology 42
- Molecular Biology 61
- Surgery 33
Countries citing papers authored by Emily Lemke
This map shows the geographic impact of Emily Lemke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emily Lemke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emily Lemke more than expected).
Fields of papers citing papers by Emily Lemke
This network shows the impact of papers produced by Emily Lemke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emily Lemke. The network helps show where Emily Lemke may publish in the future.
Co-authors
The 25 scholars most cited alongside Emily Lemke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 89 | |
| 2 | 2018 | 48 | |
| 3 | 2024 | 11 | |
| 4 | 2018 | 11 | |
| 5 | 2019 | 8 | |
| 6 | Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer. | 2019 | 8 |
| 7 | 2017 | 7 | |
| 8 | 2018 | 7 | |
| 9 | 2020 | 6 | |
| 10 | 2021 | 5 | |
| 11 | 2019 | 5 | |
| 12 | 2021 | 2 | |
| 13 | 2020 | 2 | |
| 14 | 2018 | 2 | |
| 15 | 2018 | 2 | |
| 16 | 2023 | 1 | |
| 17 | [Therapy of acute exogenous intoxications using hemo- and peritoneal dialysis and results of this treatment in GDR in the years 1959-1968]. | 1970 | 1 |
| 18 | [Causes and mortality in diabetic coma]. | 1969 | 1 |
| 19 | 1970 | 1 | |
| 20 | 2026 | 0 |
About Emily Lemke
Emily Lemke is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Molecular Biology and Endocrinology, Diabetes and Metabolism, having authored 20 papers that have together received 217 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (8 papers), Bladder and Urothelial Cancer Treatments (6 papers), Urinary and Genital Oncology Studies (5 papers), Renal and related cancers (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Cancer Genomics and Diagnostics (2 papers) and Diabetes Management and Research (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (154 citations), Cancer Research (45 citations), Oncology (42 citations), Molecular Biology (61 citations) and Surgery (33 citations). Emily Lemke has collaborated with scholars based in United States and Spain. Frequent co-authors include Amishi Y. Shah, Nizar M. Tannir, Matthew T. Campbell, Eric Jonasch, Pavlos Msaouel, Jianjun Gao, Anuradha Chandramohan, Martin H. Voss, Padmanee Sharma and Joshua Chaim. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, Clinical Genitourinary Cancer, Annals of Oncology and Oncology nursing forum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.